메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Xinhua Silk Road: E. China's Longkou City releases "Legend of Xu Fu" cultural IP to boost international exchange

Beijing, Jan. 28, 2026 -- Longkou City in east China's Shandong Province recently launched the "Legend of Xu Fu" cultural IP and debuted its first comic book series. The initiative aims to leverage the historical legacy of Xu Fu as a bridge to further deepen cultural exchange with Japan, Republic of Korea, and the international community. The "Legend of Xu Fu" is based on the historical account of the Qin Dynasty alchemist's voyage to the east, integrating mythological elements from the Classic of Mountains and Seas (Shanhaijing) with maritime adventure narra
- 김장윤(JASON KIM) 기자
- 2026-01-28 15:00
Meet Japan's Master Artisans at the 4th Annual Japan Traditional Crafts Ginza Artisan's Street

A six-day celebration of master artisans, live demonstrations, and hands-on cultural experiences in the heart of Tokyo TOKYO, Jan. 28, 2026 -- From Wednesday, February 18 to Monday, February 23, 2026, Matsuya Ginza will host the 4th Annual Japan Traditional Crafts Ginza Artisan's Street, Ginza Meishoichi, a six-day showcase bringing together master artisans and traditional Japanese crafts from approximately 90 regions across Japan. Organized by The Association for the Promotion of Traditional Craft Industries and hosted at Matsuya Ginza, the annual event offers visitors
- 김장윤(JASON KIM) 기자
- 2026-01-28 14:28
제5회 미래 광물 포럼, 참가자 2만 1500명 기록 및 미화 266억 달러 규모 계약 체결하며 성료

[ 메디채널 황정호 기자 ] 리야드, 사우디아라비아, 2026년 1월 28일 -- 산업광물자원부(Ministry of Industry and Mineral Resources)는 전 세계의 투자 리더, 주요 광업 기업 대표, 전문가 및 기술 전문가를 포함해 2만 1500명의 참가자라는 기록적인 출석과 함께 제5회 미래 광물 포럼(Future Minerals Forum, FMF)의 성공적인 종료를 발표했다. 2026년 1월 13일부터 15일까지 리야드의 킹 압둘아지즈 국제 컨퍼런스 센터(King Abdulaziz International Conference Center)에서 개최된 이 포럼에서는 총 미화 266억 달러에 달하는 132건의 계약 및 양해각서가 체결됐다. 이러한 계약 및 양해각서는 탐사 및 채굴, 금융, 연구개발, 혁신, 지속가능성, 부가가치 공급망 및 광업 산업 등 중요한 분야들을 다뤘다. 폐막 연설에서 반다르 알코라이예프(Bandar Alkhorayef) 산업광물자원부 장관은 이번 포럼에서 확인된 전례 없는 추진력이 더 넓은 글로벌 광업 생태계 전반의 진보를 반영한다고 언급했다. 그는 지난 5년 동안
- 황정호 기자
- 2026-01-28 14:15
TIGER® AWAKENS FIVE-LION 'HUAT SQUAD' TO OFFICIALLY KICK OFF ITS CHINESE NEW YEAR CELEBRATIONS

[ 메디채널 김장윤(JASON KIM) 기자 ] Following its official unveiling at Clarke Quay, Tiger's first-of-its-kind five-lion dance troupe ushers in the brand's Chinese New Year celebrations across the island, from festive roadshows to digital greetings. SINGAPORE, Jan. 28, 2026 -- As Singapore's iconic homegrown beer, Tiger officially kicked off its Chinese New Year celebrations last Thursday evening at Clarke Quay, unveiling and "awakening" its first-ever five-lion dance troupe, the Huat Squad, in a traditional officiation ceremony. The five-lion dance troupe, Huat Squad
- 김장윤(JASON KIM) 기자
- 2026-01-28 14:03
Mobile Legends: Bang Bang charts global ambitions with five-region esports overhaul, M8 World Championship breaks ground in Türkiye and Thailand

[ 메디채널 황정호 기자 ] MLBB is the first confirmed title for the inaugural Esports Nation Cup (ENC) 2026 and will debut as a medalled event at the 20th Asian Games Aichi-Nagoya 2026. MLBB Esports unveiled a new intercontinental tournament piloting across AMER, EA, and SEA—the Championship Tour—to elevate regional competition. The M7 World Championship becomes the most-watched mobile esports event of all time with 5.68 million Peak Concurrent Viewers (PCV), according to Esports Charts. JAKARTA, Indonesia, Jan. 28, 2026 -- Mobile Legends: Bang Bang (MLBB) enters a bold new era of globa
- 황정호 기자
- 2026-01-28 14:02
Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More

Hanmi Signs Exclusive Partnership with New Mexican Partner Laboratorios Sanfer, Covering Efpeglenatide and Diabetes Treatments SEOUL, South Korea, Jan. 28, 2026 -- Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 class obesity and metabolic disease treatment. Hanmi Pharmaceutical, the core operating company of Hanmi Science, announced on January 28 that it has signed an exclusive distribution agreement with Mexican pharmaceutical company Laboratorios Sanfer for efpeglenatide, its GLP-1 obesity the
- 김갑성 기자
- 2026-01-28 12:08
A New Era in Options Trading! Futu Partners with Nasdaq to Deliver Monday & Wednesday Expirations for Greater Flexibility and Opportunity

HONG KONG, Jan. 28, 2026 -- Futu Holdings Limited (Nasdaq: FUTU) ("Futu"), a leading securities trading and wealth management fintech platform, today announced that its Futubull and overseas independent brand Moomoo platforms will launch support for Nasdaq's newly introduced Monday and Wednesday options on day one, making Futu one of the first brokers to offer this innovation. This move once again positions Futu at the forefront of the industry in providing top-tier derivatives tools, further meeting the growing global investor demand for flexible options [1] trading and pre
- 황정호 기자
- 2026-01-28 12:08
CNN International Teams Up with Hyundai Motor Company for global campaign including exclusive sponsorship of new CNN Originals Series, K-Everything

HONG KONG, Jan. 28, 2026 -- CNN International Commercial (CNNIC) and Hyundai Motor Company (Hyundai Motor) are expanding the long-term partnership between the two companies with a new enhanced global campaign that will connect Hyundai Motor with CNN's worldwide audience in new ways. This campaign includes Hyundai Motor being the exclusive sponsor of K-Everything: a CNN Originals Series which will trace the roots of Korean culture with some of the biggest names in Korea's creative scene. From Seoul to Singapore and beyond, the four-part series delves into the passion, in
- 김장윤(JASON KIM) 기자
- 2026-01-28 12:02
US FDA Approves First Daily Oral GLP‑1 Treatment for Weight Management, Showing Comparable Results to Injectable Therapy

[ 메디채널 김갑성 기자 ] The US Food and Drug Administration (FDA) has approved Novo Nordisk's new once-daily pill for weight management, designed to help people reduce excess body weight and maintain weight reduction over the long term. In clinical trials, patients achieved an average weight reduction of 16.6% from baseline. The therapy is also indicated to lower the risk of major cardiovascular events* such as heart attack and stroke in certain patients. Novo Nordisk expects to launch the pill in the United States in early January 2026. JAKARTA, Indonesia, Jan. 28, 2026 -- [ 메디채널 김갑성 기자 ]
- 김갑성 기자
- 2026-01-28 10:45
Longbridge Securities' user asset grew 220% YoY in 2025, as it built an AI-native investing experience

SINGAPORE, Jan. 28, 2026 -- Throughout 2025, Longbridge Securities continued to place technological innovation at the core of its strategy, and steadily expanded its global investment services. Beyond connecting investors to global markets, Longbridge further explored how investment can be integrated into everyday life. Building on its strong growth momentum, the annual user assets increased by 220% and the global user base grew by 120%. Outside Singapore, Longbridge Securities is the fastest-growing fintech brokerage in the Hong Kong market. Solid growth across key business metrics, g
- 황정호 기자
- 2026-01-28 10:20

이전

91 92 93 94 95 96 97 98 99 100

많이 본 기사

최근기사

2026-03-03_TUE

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 03일 03시 40분